M. Daniel

Neflamapimod induces vasodilation in resistance mesenteric arteries by inhibiting p38 MAPKα and downstream Hsp27 phosphorylation

Farzana Zerin, Sreelakshmi N. Menon, Khue P. Nguyen, 2022, Scientific Reports.

University of Birmingham Extracellular SPARC increases cardiomyocyte contraction during health and disease

S. Heymans, K. Sipido, M. Rienks, 2019 .

Neflamapimod Induces Vasodilation in Resistance Mesenteric Arteries by Inhibiting p38 Mitogen-Activated Protein Kinase Alpha (MAPKα) and Heat-Shock Protein 27 (Hsp27) Phosphorylation

A. Pandey, Farzana Zerin, Sreelakshmi N. Menon, 2021 .

Neflamapimod inhibits endothelial cell activation, adhesion molecule expression, leukocyte attachment and vascular inflammation by inhibiting p38 MAPKα and NF-κB signaling.

Farzana Zerin, Sreelakshmi N. Menon, Sherif Hafez, 2023, Biochemical pharmacology.